Delivery Order SPE2DR25D3201-SPE2DR26FT4EG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,938.89 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) on November 5, 2025, with completion targeted for November 6, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Narcan 4 mg nasal spray (two-count packages) with a ceiling value of $3,574.16. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $2,615.88 delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) under a firm fixed-price contract valued at $8,582.41, with completion required by July 2, 2025. The order was competitively awarded without set-aside restrictions and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.44 to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-pack units) on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's established Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 1, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) valued at $3,391.20 with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract issued by the Medical Supply Chain, a division of the Defense Logistics Agency supporting the Department of Defense. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,240.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (two-unit package) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to deliver this emergency...
- The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4EGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Narcan 4 mg nasal spray in 2-pack units, with a contract ceiling value of $1,421.56 and an ultimate completion date of November 21, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, delivering everything from specialty medications and brand-name drugs to vaccines and medical devices across multiple therapeutic domains. This award reflects AmerisourceBergen's role within the DLA's pharmaceutical supply chain, supporting Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to meet evolving federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/20/25 |